Filing Details

Accession Number:
0001127602-23-013708
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-28 06:46:20
Reporting Period:
2023-04-27
Accepted Time:
2023-04-28 06:46:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1878313 Maia Biotechnology Inc. MAIA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1913199 Stan Smith 444 West Lake Street, Suite 1700
Chicago IL 60606
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-27 133,300 $2.25 686,628 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. These shares were purchased by the reporting person in the issuer's follow-on offering, which closed on April 27, 2023.
  2. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.